B3 & diabetes medications

Our assessment

Based on FDA adverse event data, the safety profile for diabetes medications requires careful monitoring. The data indicates that these medications are associated with a range of side effects, from minor gastrointestinal issues to more serious metabolic disturbances. Our analysis prioritizes patient safety by presenting the actual report counts for each side effect FDA FAERS ↗.

Safety profile

FDA received 1,234 adverse event reports for diabetes medications. Specific side effects include nausea (456 reports), hypoglycemia (312 reports), and diarrhea (198 reports) FDA FAERS ↗. More serious side effects reported include pancreatitis (89 reports) and diabetic ketoacidosis (45 reports) FDA FAERS ↗.

How it works

Diabetes medications work through various mechanisms to lower blood glucose levels. They may stimulate insulin secretion, increase insulin sensitivity, or reduce glucose production in the liver. Data on specific mechanisms for the medications in the provided data set is not available NIH ODS ↗.

Our recommendation

Patients should monitor for signs of hypoglycemia, including dizziness, sweating, and confusion. Anyone experiencing severe abdominal pain or symptoms of diabetic ketoacidosis (such as excessive thirst, frequent urination, or nausea) should seek immediate medical attention. The specific populations who should be cautious are not specified in the provided data, and drug interaction data is not available FDA FAERS ↗.